Insiders / Cohlhepp Ryan / Activity

Activity — Cohlhepp Ryan

15 moves.

BiggestBiggest buysBiggest sellsHighest impact
InsidersInstitutions
DateActionCompanyValueShares ΔPosition afterImpact
Mar 3, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$234.2K-13K
-5.79%
209,641
0.32% of shares
medium
Mar 16, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$157.3K-8K
-3.75%
205,141
0.31% of shares
medium
Mar 16, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$88.5K-5K
-2.19%
200,641
0.30% of shares
low
Mar 3, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$81.7K-5K
-2.15%
205,141
0.31% of shares
low
Jan 22, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$69.3K-4K
-1.79%
210,164
0.32% of shares
low
Feb 25, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$56.1K-3K
-1.46%
210,164
0.32% of shares
low
Mar 3, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Common Stock
$48.9K+13K
+6.15%
222,533
0.34% of shares
low
Mar 16, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Common Stock
$30.3K+8K
+3.90%
213,141
0.32% of shares
low
Feb 25, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Common Stock
$11.8K+3K
+1.48%
213,272
0.32% of shares
low
Feb 25, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$9.4K-523
-0.25%
209,641
0.32% of shares
low
Jan 15, 2026SellBCAX
Bicara Therapeutics Inc.
Common Stock
$2.7K-149
-0.07%
213,992
0.32% of shares
low
Mar 16, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Stock Option (Right to Buy)
—-8K
-6.38%
117,334
0.18% of shares
low
Mar 3, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Stock Option (Right to Buy)
—-13K
-9.33%
125,334
0.19% of shares
low
Feb 25, 2026ExerciseBCAX
Bicara Therapeutics Inc.
Stock Option (Right to Buy)
—-3K
-2.20%
138,226
0.21% of shares
low
Feb 2, 2026GrantBCAX
Bicara Therapeutics Inc.
Stock Option (Right to Buy)
—+300K
300,000
0.45% of shares
low
← PrevPage 1 of 1Next →